Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

VENUS REMEDIES LTD.

NSE : VENUSREMBSE : 526953ISIN CODE : INE411B01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE897.4032.3 (+3.73 %)

PREV CLOSE ( ) 865.10

OPEN PRICE ( ) 860.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 16603

TODAY'S LOW / HIGH ( )844.00 908.35

52 WK LOW / HIGH ( )285.8 950

NSE896.6035.55 (+4.13 %)

PREV CLOSE( ) 861.05

OPEN PRICE ( ) 833.60

BID PRICE (QTY) 896.60 (68)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 94779

TODAY'S LOW / HIGH( ) 831.10 904.10

52 WK LOW / HIGH ( )285.7 944.75

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1989

Management Info

Pawan Chaudhary - Chairman Pawan Chaudhary - Managing Director

Registered Office

Address S. C. O. 857, C. No. 10,2nd Floor,N A C Manimajra,
Chandigarh,
Union Territory-160101

Phone 0172-2561244/5577

Email info@venusremedies.com

Website www.venusremedies.com / www.vmrcindia.com

Registrars Details

MUFG Intime India Pvt Ltd.

Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi

Listing : BSE, NSE

NEWS

19Jan Venus Remedies informs about board mee
Venus Remedies has informed that the meeting of Board of Directors is sc..

09Jan Venus Remedies gets marketing authoriz
Venus Remedies has received marketing authorisation in Indonesia for its..

09Jan Venus Remedies soars on getting market
Venus Remedies is currently trading at Rs. 727.00, up by 15.75 points or..

08Dec Venus Remedies informs about press rel
Venus Remedies has informed about press release titled - 'Venus Remedies..

01Dec Venus Remedies informs about update o
Venus Remedies has informed that the company has concluded all pending I..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	249.2	525.5
Gross Profit	328.1	790.6
Operating Profit	391.3	907.7
Net Sales	1799.5	6394.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE) 2146.70 (3.09%)	M.Cap ( in Cr)1326.24
Hester Biosciences (BSE) 1427.90 (4.01%)	M.Cap ( in Cr)1214.70
Haleos Labs (BSE) 1299.00 (3.61%)	M.Cap ( in Cr)392.72
RPG Life Sciences (BSE) 1922.95 (2.35%)	M.Cap ( in Cr)3180.37
Albert David (BSE) 653.15 (6.34%)	M.Cap ( in Cr)372.76

Shareholding Pattern

	NON-INSTITUTION	54.96%
	PROMOTERS	41.76%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

VENUS REMEDIES LTD.